Liver Disease - Xconomy

by in

Entry	Author	Date	Location
Lumena Raises $23 Million to Advance Drug for Rare Liver Diseases	Bruce V. Bigelow	05/08/13	San Diego
San Diego Life Sciences Roundup: Avalon’s GSK Deal, Illumina, & More	Bruce V. Bigelow	04/25/13	San Diego
San Diego Life Sciences Roundup: Halozyme, Acadia, Trovagene, & More	Bruce V. Bigelow	03/29/13	San Diego
San Diego Life Sciences Roundup: Allergan, Qualcomm Life, & More	Bruce V. Bigelow	11/21/12	San Diego
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News	Bruce V. Bigelow	06/30/11	San Diego
Conatus Raises $20M for Hepatitis C Studies	Bruce V. Bigelow	02/14/11	San Diego
Ligand Licenses Liver Drug Candidates	Bruce V. Bigelow	01/06/11	San Diego
Conatus Gets Pfizer Subsidiary	Erin Kutz	08/02/10	San Diego
FDA Approves Over-the-Counter Version of Santarus Drug, Pioneer of Algal Biofuels Says Algae Will Make Drugs Too, Receptos Gets $25M, & More San Diego Life Sciences News	Bruce V. Bigelow	12/02/09	San Diego
Ocera Therapeutics, Pursuing New Drug for Liver, Hopes to Help People Stay Mentally Sharp	Luke Timmerman	11/25/09	San Diego
Vertex Drug for Hepatitis C Shows Durable Virus-Killing Ability in Tough-to-Treat Patients	Luke Timmerman	11/01/08	Boston
Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds	Luke Timmerman	11/01/08	San Diego
Page 1 of 1

Xconomy National